Search research articles
Contact Us
Filters
Showing results (241-250 of 440) with videos related to
Page
of 44
Sort By:
Nature Communications
|
April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Cristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Nature Genetics
|
March 7, 2020
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
Saioa López, Emilia L Lim, Stuart Horswell, et al.
The Journal of Clinical Investigation
|
April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy
Yeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2014
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients
Sietske B M Gaykema, Carolien P Schröder, Joanna Vitfell-Rasmussen, et al.
The Lancet. Oncology
|
March 13, 2019
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Funda Meric-Bernstam, Herbert Hurwitz, Kanwal Pratap Singh Raghav, et al.
Lancet (London, England)
|
January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
Edward J Carr, Mary Wu, Ruth Harvey, et al.
NAR Cancer
|
June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
Francesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.
Cancer Discovery
|
January 11, 2017
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Laurent Sansregret, James O Patterson, Sally Dewhurst, et al.
The Journal of Pathology
|
October 15, 2013
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas
Marco Gerlinger, Sergio A Quezada, Karl S Peggs, et al.
Page
of 44
Search research articles
Search
Showing results (241-250 of 440) with videos related to
Sort By:
Page
of 44
Nature Communications
|
April 15, 2020
Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis
Cristina Morales Torres, Mary Y Wu, Sebastijan Hobor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2023
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Christopher J Sweeney, John D Hainsworth, Ron Bose, et al.
Nature Genetics
|
March 7, 2020
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
Saioa López, Emilia L Lim, Stuart Horswell, et al.
The Journal of Clinical Investigation
|
April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapy
Yeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2014
89Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients
Sietske B M Gaykema, Carolien P Schröder, Joanna Vitfell-Rasmussen, et al.
The Lancet. Oncology
|
March 13, 2019
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study
Funda Meric-Bernstam, Herbert Hurwitz, Kanwal Pratap Singh Raghav, et al.
Lancet (London, England)
|
January 23, 2022
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
Edward J Carr, Mary Wu, Ruth Harvey, et al.
NAR Cancer
|
June 6, 2022
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
Francesco Orlando, Alessandro Romanel, Blanca Trujillo, et al.
Cancer Discovery
|
January 11, 2017
APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability
Laurent Sansregret, James O Patterson, Sally Dewhurst, et al.
The Journal of Pathology
|
October 15, 2013
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas
Marco Gerlinger, Sergio A Quezada, Karl S Peggs, et al.
Page
of 44